Clinical Trials Browser

Phase 1/2 × brostallicin × Plasma cell × Clear all

NCT00060203 2014-01-16

Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell